Statistics

Total Visits

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program49

Select a period of time:

Number of views in the range

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program20

Views

Views
July 202511
August 20251
September 20253
October 20252
November 20252
December 20251
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil7
Argentina4
United Kingdom3
United States2
Austria1
Colombia1
Hong Kong1
Italy1
 

Top cities views

Views
Barranquilla1
Buenos Aires1
Campinas1
Campo Grande1
Canoinhas1
Cornélio Procópio1
Dallas1
Diamantina1
Duns1
Goiânia1